Certolizumab pegol-induced palmoplantar pustulosis: A case report and review of the literature

Reumatol Clin (Engl Ed). 2019 Nov-Dec;15(6):e163-e165. doi: 10.1016/j.reuma.2017.12.004. Epub 2018 Jan 19.

[Article in English, Spanish]

Authors

Lourdes Villalobos-Sánchez¹, Carmen Larena-Grijalba², Adela Alía-Jiménez², Walter Alberto Sifuentes-Giraldo²

Affiliations

¹ Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, España. Electronic address: lurdesvs@hotmail.com.
² Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, España.

PMID: 29370988
DOI: 10.1016/j.reuma.2017.12.004

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Arthritis, Rheumatoid / drug therapy
Certolizumab Pegol / adverse effects*
Foot Dermatoses
Hand Dermatoses / chemically induced*
Humans
Immunosuppressive Agents / adverse effects*
Male
Middle Aged
Psoriasis / chemically induced*
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Immunosuppressive Agents
Tumor Necrosis Factor-alpha
Certolizumab Pegol